Standout Papers
Immediate Impact
2 from Science/Nature 66 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Principles and therapeutic applications of adaptive immunity
2024 Standout
Works of Agnès Guerci‐Bresler being referenced
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia
2017
EPIC: A phase III trial of ponatinib (PON) versus imatinib (IM) in patients (pts) with newly diagnosed CP-CML.
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Agnès Guerci‐Bresler | 1339 | 1121 | 536 | 53 | 1.4k | |
| Sandip Shah | 1081 | 860 | 542 | 45 | 1.4k | |
| Verity A Saunders | 1217 | 993 | 558 | 61 | 1.6k | |
| Clarisse Lobo | 1264 | 1092 | 639 | 23 | 1.5k | |
| Phuong Dang | 1362 | 1119 | 632 | 30 | 1.6k | |
| Franck E. Nicolini | 1430 | 1187 | 685 | 64 | 1.6k | |
| Pascale Cony‐Makhoul | 1222 | 843 | 496 | 76 | 1.5k | |
| Jenny Shan | 1135 | 905 | 597 | 26 | 1.2k | |
| Sélim Corm | 996 | 696 | 435 | 43 | 1.3k | |
| Saengsuree Jootar | 1143 | 896 | 506 | 74 | 1.5k | |
| Anna Turkina | 1088 | 954 | 516 | 120 | 1.4k |
All Works
Loading papers...